123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease (Q48011827)

7 February 2018

title

123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease (English)

1 reference

7 February 2018

1 reference

5

Poewe W

1 reference

7 February 2018

Wenning GK

1

1 reference

7 February 2018

Donnemiller E

series ordinal

2

1 reference

7 February 2018

Granata R

series ordinal

3

1 reference

7 February 2018

Riccabona G

series ordinal

4

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

7 February 2018

published in

Movement Disorders

1 reference

7 February 2018

volume

13

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

438-445

1 reference

7 February 2018

The natural history of Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Clinical and [18F] dopa PET findings in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Correction for photon attenuation in SPECT: analytical framework, average attenuation factors, and a new hybrid approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/MDS.870130311

21 January 2018

Identifiers

DOI

10.1002/MDS.870130311

1 reference

7 February 2018

release_zwhz27eqgnfltdonxroormhiu4

Fatcat ID

0 references

1 reference

7 February 2018